Despite the delay, Mirna has gained some traction in its efforts to form an industry partnership, having inked technology-evaluation deals with two pharmaceutical companies.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.